Former Blackrock fund manager Edward Dowd paints a grim picture for Big Pharma’a vax kings in a recent interview with Thomas Paine.
Dowd, who grew his fund to $14B by anticipating the next big news, believes bankruptcy is in the cards for the Pharma giants.
“Wall Street is… starting to smell something went really wrong during the whole EUA clinical trials process… Pfizer’s clinical trial data was fraudulent. They didn’t report the all cause mortality endpoint, which is the gold standard in the drug approval process. They failed that endpoint but they rammed it through,” Dowd said.
Comparing the situation to the Great Financial Crisis, Dowd points out that in both cases, “the supposed watchdog… wasn’t an objective, disinterested party.” Leading up to 2008, “they gave AAA ratings to bonds that lost 60%, which never should have happened.” In Covid-1984, instead of the ratings agencies facilitating the con, it’s the federal government. “The FDA gets 50% of its budget from Pharma. The fraud couldn’t have been perpetuated without CDC and FDA help,” explained Dowd.
The falsified trial data and adverse event reports are being “heavily suppressed by our tech overlords and the mainstream media,” Dowd continued. “This couldn’t have happened without their silence and/or active suppression. I view this as a multi-siloed fraud, called meta-fraud: There’s Pharma [where] the fraud originated… media and tech censoring the truth [in exchange for] Pharma spend… and then you’ve got the government, which was corrupted…”
“It’s all going to unravel,” Dowd predicts. “People have become rich off of the death and disability of others… Forget about conspiracy theory. This is good old fashioned greed and power… Let me tell you what Pfizer’s potential revenues could be if they are successful in mandating this vaccine quarterly… Their revenues go from $52B to $350B overnight… If you don’t think that’s enough incentive to bribe government officials, you’re naive.”
Dowd believes Big Insurance will be the catalyst that causes the wheels to come off. Major life insurance firms are reporting multi-sigma increases in non-Covid-related death claims.
OneAmerica saw deaths climb 40% among the 18 – 64 age cohort during the third quarter of 2021 from the prior year. “Just to give you an idea of how bad that is, a three-sigma or a one-in-200-year catastrophe would be 10% increase over pre-pandemic,” CEO Scott Davison said. “So 40% is just unheard of.”
Reuters reported that Dutch insurer Aegon, which does two-thirds of its business in the United States, is facing a similar brobdingnagian spike: “claims in the Americas in the third quarter were $111 million, up from $31 million a year earlier.”
“Once the [life insurance] trial lawyers get involved in this discovery, that’s when the kimono opens up and the flood gates open,” Dowd argues. “It gets wild and woolly then. But that’s further down the road once their stock prices have already been beaten into submission.”
What about the blanket immunity protection for vaccine manufacturers, Paine asked. “Fraud eviscerates all contracts,” Dowd responded. “Moderna and Biontech are going to zero… Pfizer could be a $5 stock.”
